Show simple item record

dc.contributor.authorKavanagh, Madeline E.
dc.contributor.authorGray, Janine L.
dc.contributor.authorGilbert, Sophie H.
dc.contributor.authorCoyne, Anthony G.
dc.contributor.authorMcLean, Kirsty J.
dc.contributor.authorDavis, Holly J.
dc.contributor.authorMunro, Andrew W.
dc.contributor.authorAbell, Chris
dc.descriptionThis data is submitted in support of the manuscript entitled "Substrate fragmentation for the design of M. tuberculosis CYP121 inhibitors", which has been accepted for publication in the journal ChemMedChem, and has the DOI: 10.1002/cmdc.201600248. The characterisation data (IR, HRMS, LCMS, NMR) for compounds synthesised in this research are provided as PDF files. The EPR (narrow and wide scan) raw data is provided for compounds as csv files. The difference spectra for the titration of CYP121 with the ligands described in the study are provided as csv files.en
dc.description.sponsorshipBBSRC (BB/I019669/1)
dc.description.sponsorshipBBSRC (BB/I019227/1)
dc.description.sponsorshipWellcome Trust (GR080083/Z/06)
dc.description.sponsorshipCambridge Commonwealth Trust and Cambridge Overseas Trust (AUCR-2013-3)
dc.formatadobe, excel, originen
dc.publisherUniversity of Cambridgeen
dc.rightsAttribution 4.0 International*
dc.subjectMycobacterium tuberculosisen
dc.subjectsubstrate fragmentationen
dc.subjectfragment-based drug discoveryen
dc.titleResearch Data Supporting "Substrate fragmentation for the design of M. tuberculosis CYP121 inhibitors"en
datacite.contributor.supervisorAbell, Chris
dcterms.formatpdf, csv
dc.contributor.orcidKavanagh, Madeline [0000-0002-4735-1559]

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International